Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a research note issued on Monday. The firm set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

Shares of CO stock opened at $1.05 on Monday. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The stock has a market cap of $127.63 million, a P/E ratio of 1.64 and a beta of 0.16. The stock has a fifty day moving average price of $1.40 and a 200 day moving average price of $1.40.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.